A recombinant vaccine is a vaccine produced through recombinant DNA technology. This involves inserting the DNA encoding an antigen (such as a bacterial surface protein) that stimulates an immune ...

A recombinant protein therapy is produced through recombinant DNA technology, which involves inserting the DNA encoding the protein into bacterial or mammalian cells, expressing the protein in ...

The proteinase k market is expected to reach approximately USD 30.2 million in 2025 and expand to around USD 48.2 million by 2035, reflecting a compound annual growth rate (CAGR) of 4.8% over the ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

The publication introduces a genetic identification system that enables plasmids to carry embedded documentation, improving ...

New DNA analysis technology made available to local police agencies will speed up the testing process in criminal cases, which could lead to identifying suspects much faster, law enforcement ...

The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years. Advancements in genetic ...

Plastic milk jugs are a ubiquitous part of the American supermarket landscape, but one feature of these containers has ...

One of the greatest transformations in modern medicine arguably began with a corned beef sandwich.It was the late 1960s, and ...

NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based platform built on stable cell line ...

The veterinary vaccines market is estimated to reach USD 9,433.9 million in 2024. It is estimated that revenue will increase ...

New studies stemming from the Armamentarium consortium outline findings that advance tools based on Adeno-associated virus ...